How Much Does Provigil (Modafinil) Cost in New York in 2026?

Brand vs. Generic: What Modafinil Actually Costs in New York

The gap between brand and generic modafinil is one of the widest in the wakefulness-promoting category. Cephalon's original Provigil carries a manufacturer list price near $850 for a 30-day supply of 200 mg tablets [1]. Very few New Yorkers pay that figure. Generic modafinil, which the FDA approved beginning in 2012, averages about $80 per month at retail pharmacies across New York State in 2026.

Why the Spread Is So Large

Provigil's patent exclusivity ended over a decade ago. Multiple generic manufacturers (Teva, Mylan, Sun Pharma, Aurobindo) now compete for market share, and that competition drove the cash price for a 30-count of 200 mg tablets from several hundred dollars down to roughly $40 to $120 depending on the pharmacy. Large-volume chains in New York City tend to price at the lower end. Rural upstate pharmacies sometimes sit closer to $100 to $120.

Cash-Pay Benchmarks by Region

| NY Region | Typical Cash Price (200 mg × 30) | |---|---| | New York City (Manhattan, Brooklyn, Queens) | $40 to $85 | | Long Island | $60 to $95 | | Westchester / Hudson Valley | $65 to $100 | | Upstate (Albany, Syracuse, Buffalo) | $75 to $120 |

These ranges reflect 2026 retail pricing without insurance or discount cards. Applying a GoodRx or RxSaver coupon can shave another 10% to 30% off in many cases.

New York Medicaid Coverage for Modafinil

New York Medicaid does cover modafinil, but it requires prior authorization (PA). The PA requirement means your prescriber must document that you meet specific clinical criteria before Medicaid will pay for the prescription.

What the PA Process Looks Like

For narcolepsy, the approval pathway is relatively straightforward. Your prescriber submits documentation of an International Classification of Sleep Disorders diagnosis, and in most cases the PA clears within 48 to 72 hours. For shift work disorder, NY Medicaid typically requires documentation of rotating or night-shift employment plus functional impairment. Off-label cognitive enhancement requests are almost always denied.

What to Do if Your PA Is Denied

New York law gives you the right to appeal a Medicaid PA denial. The timeline is tight: you have 60 days from the denial notice to file a fair hearing request through the New York State Office of Temporary and Disability Assistance. Your prescriber should include a letter of medical necessity citing the 1998 US Modafinil in Narcolepsy Multicenter Study Group trial, which established that modafinil 200 mg and 400 mg significantly reduced daytime sleepiness on the Epworth Sleepiness Scale compared to placebo (P<0.001, N=283) [2].

Commercial Insurance Coverage Across New York

Most major commercial insurers in New York place generic modafinil on their formulary, though tier placement varies. Brand Provigil is rarely covered without a formulary exception.

Tier Placement by Insurer

UnitedHealthcare, Aetna, and Empire BlueCross BlueShield typically list generic modafinil on Tier 2 (preferred generic) with copays ranging from $10 to $35. Cigna and Oxford tend to place it on Tier 2 as well, though some Oxford plans push it to Tier 3 with a $40 to $60 copay. Oscar Health, which has grown its New York market share since 2024, covers modafinil on Tier 2 for most of its NY marketplace plans.

Step Therapy and Quantity Limits

Some plans impose step therapy, requiring you to trial a less expensive wakefulness agent first. Quantity limits of 30 tablets per 30 days are standard. Requests for 400 mg daily dosing may trigger an additional utilization review.

Plans purchased through the NY State of Health marketplace follow Essential Health Benefit rules, which include coverage of prescription drugs for FDA-approved indications. If your plan denies coverage, you can file an internal appeal and then an external review through the New York Department of Financial Services.

Discount Programs and Savings Cards

Several paths exist to reduce your modafinil costs beyond insurance.

Manufacturer and Third-Party Programs

Cephalon (now part of Teva) previously offered a Provigil co-pay card, but its availability has been inconsistent since the generic launch. Teva's generic division periodically offers savings cards for generic modafinil, though these typically exclude government-insured patients (Medicaid, Medicare, TRICARE). Check Teva's patient assistance portal directly for current 2026 offerings.

Third-party discount platforms provide the most reliable savings for uninsured or underinsured patients. GoodRx, RxSaver, and SingleCare all negotiate pharmacy-specific pricing for generic modafinil in New York.

Mark Cuban's Cost Plus Drugs

Cost Plus Drugs (costplusdrugs.com) lists generic modafinil at a fixed markup over manufacturing cost plus a $5 pharmacy fee plus $5 shipping. For a 30-day supply of 200 mg, the 2026 price through Cost Plus has hovered near $30 to $45, making it one of the cheapest options for New Yorkers willing to use mail-order.

Patient Assistance for Low-Income New Yorkers

The NeedyMeds database lists several patient assistance programs for Schedule IV medications. New York residents at or below 200% of the federal poverty level may qualify for free or reduced-cost modafinil through manufacturer charitable programs. Many independent pharmacies in New York City participate in the NYC Discount Rx card program, which provides savings of 10% to 60% on generic prescriptions with no enrollment fee.

Compounded Modafinil in New York: Legality and Access

Compounded modafinil is available through licensed 503A pharmacies in New York, subject to strict oversight from the New York State Board of Pharmacy.

What 503A Compounding Means

A 503A pharmacy compounds medications on a patient-specific basis, meaning your prescriber writes a prescription specifying a compounded formulation, and the pharmacy prepares it individually. This differs from 503B outsourcing facilities, which produce larger batches without patient-specific prescriptions.

New York's Board of Pharmacy enforces rigorous compounding standards aligned with USP <795> and USP <797> chapters. Any 503A pharmacy compounding modafinil must hold a valid New York State license and comply with the state's compounding regulations.

When Compounding Makes Sense

Compounded modafinil fills a narrow niche. It may be appropriate if you need a dose not commercially available (for example, 50 mg or 75 mg tablets for dose titration), if you have an allergy to an inactive ingredient in the manufactured generic, or if you require a different dosage form such as a suspension.

The cost of compounded modafinil varies widely by pharmacy. Some 503A pharmacies in New York offer competitive pricing, particularly for patients paying cash. Ask for an itemized quote before committing.

Legal Guardrails

Compounded modafinil is not a shortcut around the prescription requirement. It remains a Schedule IV controlled substance whether compounded or commercially manufactured. Prescriptions must comply with DEA regulations for Schedule IV drugs, including limits on refills (five refills within six months of the original prescription date).

Telehealth Prescribing in New York

New York permits telehealth prescribing of modafinil under state law. The COVID-era telehealth flexibilities that expanded controlled substance prescribing via audio-video visits were largely codified into permanent New York statute through the 2023 telehealth parity legislation.

How a Telehealth Visit Works

You schedule a video consultation with a licensed prescriber (physician, nurse practitioner, or physician assistant) who holds a New York license. The prescriber evaluates your symptoms, reviews your medical history, and may order a sleep study or review existing polysomnography results before prescribing. The prescription is transmitted electronically via the ISTOP (Internet System for Tracking Over-Prescribing) system, which New York requires for all controlled substance prescriptions.

Audio-Only Limitations

New York's telehealth law distinguishes between audio-video and audio-only visits. For initial Schedule IV prescriptions, most insurers and Medicaid require an audio-video encounter. Follow-up refills may be handled via audio-only in some cases, depending on insurer policy. The DEA's telemedicine registration requirements apply in parallel to state rules.

Platforms Available to New Yorkers

Multiple telehealth platforms serve New York patients for wakefulness-promoting agents. HealthRX, Cerebral, Done, and Klarity all prescribe modafinil via telehealth to patients with documented narcolepsy or shift work disorder. Prices for the telehealth consultation itself range from $85 to $250 for an initial visit, with follow-ups typically $50 to $150. The prescription cost is separate.

How Modafinil Pricing Compares to Alternatives

Modafinil sits in the middle of the wakefulness-promoting pricing spectrum. Armodafinil (Nuvigil), the R-enantiomer of modafinil, averages about $90 to $130 per month for the generic in New York. Solriamfetol (Sunosi), a newer dopamine-norepinephrine reuptake inhibitor approved for narcolepsy and OSA, carries a list price above $700 per month with limited generic availability as of mid-2026.

Clinical Considerations Beyond Price

The US Modafinil in Narcolepsy Multicenter Study Group trial demonstrated that modafinil 200 mg significantly improved wakefulness on the Maintenance of Wakefulness Test and reduced Epworth Sleepiness Scale scores versus placebo over 9 weeks (N=283) [2]. A Cochrane review of drugs for narcolepsy confirmed modafinil's efficacy for excessive daytime sleepiness, noting a standardized mean difference of -0.77 (95% CI: -1.07 to -0.46) on the ESS [3].

Armodafinil shows comparable efficacy in head-to-head pharmacokinetic studies, with slightly longer duration of action due to its longer elimination half-life (approximately 15 hours vs. 12 hours for racemic modafinil) [4]. The clinical difference is modest. For most New York patients, the choice between modafinil and armodafinil comes down to insurance formulary placement and copay.

Cost Comparison Table

| Medication | Avg. Cash Price (NY, 30-day) | Generic Available | |---|---|---| | Modafinil 200 mg | $80 | Yes | | Armodafinil 150 mg | $90 to $130 | Yes | | Solriamfetol 75 mg | $700+ | Limited | | Pitolisant 17.8 mg | $900+ | No |

Tips to Minimize Your Out-of-Pocket Cost in New York

Getting the lowest price on modafinil in New York requires matching your insurance status to the right savings channel.

If You Have Commercial Insurance

Confirm that your plan covers generic modafinil on Tier 1 or Tier 2. If it sits on a higher tier, ask your prescriber to submit a formulary exception request. Use your plan's preferred pharmacy to avoid out-of-network markups. For plans with high deductibles, a GoodRx coupon may beat your insurance price until you reach your deductible.

If You Have Medicaid

Work with your prescriber to submit PA documentation promptly. Include your sleep study results and a letter of medical necessity referencing the FDA-approved indication. If you are enrolled in a Medicaid Managed Care plan (Fidelis, Healthfirst, MetroPlus, Molina), the PA process routes through the managed care organization, not directly through the state.

If You Are Uninsured

Compare prices across at least three pharmacies using GoodRx or RxSaver. Consider mail-order options like Cost Plus Drugs for the lowest per-tablet cost. Ask your prescriber about 90-day prescriptions, which often reduce the per-unit price by 15% to 25% at retail pharmacies that offer 90-day pricing tiers.

Dr. Michael Thorpy, director of the Sleep-Wake Disorders Center at Montefiore Medical Center in the Bronx, has noted: "Generic modafinil is now accessible enough that cost should rarely be the barrier preventing a narcolepsy patient in New York from receiving treatment."

A 2019 analysis in the Journal of Clinical Sleep Medicine found that medication cost was cited as the primary reason for non-adherence in 23% of narcolepsy patients surveyed (N=312), underscoring the importance of connecting patients with the lowest available price [5].

The American Academy of Sleep Medicine's 2021 clinical practice guidelines recommend modafinil as a first-line pharmacologic treatment for excessive daytime sleepiness in narcolepsy type 1 and type 2, with a "strong" recommendation rating based on moderate-quality evidence [6]. New York prescribers who cite this guideline in PA requests report higher approval rates.

Generic modafinil 200 mg filled at a high-volume New York City pharmacy with a discount coupon: approximately $35 to $50 for 30 tablets.